Solaris Resources (CVE:SLS) Stock Price Down 2.7% – Here’s Why

Solaris Resources Inc. (CVE:SLS)’s share price traded down 2.7% during trading on Thursday . The stock traded as low as C$5.95 and last traded at C$6.15. 53,313 shares traded hands during mid-day trading, a decline of 60% from the average session volume of 132,199 shares. The stock had previously closed at C$6.32.

Wall Street Analysts Forecast Growth

Separately, Maxim Group lowered Solaris Resources from a “strong-buy” rating to a “hold” rating in a report on Tuesday, March 25th.

Solaris Resources Trading Down 2.7 %

The company’s fifty day simple moving average is C$6.15 and its 200 day simple moving average is C$6.15.

About Solaris Resources

SELLAS Life Sciences Group, Inc, a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer.